These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27478464)

  • 21. Sex difference in the validity of vertebral deformities as an index of prevalent vertebral osteoporotic fractures: a population survey of older men and women.
    Leidig-Bruckner G; Limberg B; Felsenberg D; Bruckner T; Holder S; Kather A; Miksch J; Wüster C; Ziegler R; Scheidt-Nave C
    Osteoporos Int; 2000; 11(2):102-19. PubMed ID: 10793868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of the Portuguese version of the quality of life questionnaire of the European foundation for osteoporosis (QUALEFFO-41) in Brazilian women with postmenopausal osteoporosis with vertebral fracture.
    de Oliveira Ferreira N; Arthuso M; da Silva RB; Pinto-Neto AM; Costa-Paiva L
    Clin Rheumatol; 2013 Nov; 32(11):1585-92. PubMed ID: 23609409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vertebral fracture assessment by dual-energy X-ray absorptiometry along with bone mineral density in the evaluation of postmenopausal osteoporosis.
    Shetty S; John B; Mohan S; Paul TV
    Arch Osteoporos; 2020 Feb; 15(1):25. PubMed ID: 32095943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of the World Health Organization Fracture Risk Assessment Tool to predict need for dual-energy X-ray absorptiometry scanning in postmenopausal women.
    Chao AS; Chen FP; Lin YC; Huang TS; Fan CM; Yu YW
    Taiwan J Obstet Gynecol; 2015 Dec; 54(6):722-5. PubMed ID: 26700992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of FRAX risk factors in osteopenic postmenopausal women with and without history of fragility fracture.
    Baró F; Cano A; Sánchez Borrego R; Ferrer J; González Rodríguez SP; Neyro JL; Rodriguez Bueno E; Sancho C; Inaraja V; Fernández C; Corral C;
    Menopause; 2012 Nov; 19(11):1193-9. PubMed ID: 22948137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strontium ranelate for preventing and treating postmenopausal osteoporosis.
    O'Donnell S; Cranney A; Wells GA; Adachi JD; Reginster JY
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005326. PubMed ID: 16856092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical risk factor status in patients with vertebral fracture but normal bone mineral density.
    Kadri A; Binkley N; Daffner SD; Anderson PA
    Spine J; 2022 Oct; 22(10):1634-1641. PubMed ID: 35680015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health-related quality of life in patients with osteopenia or osteoporosis with and without fractures in a geriatric rehabilitation department.
    Jahelka B; Dorner T; Terkula R; Quittan M; Bröll H; Erlacher L
    Wien Med Wochenschr; 2009 May; 159(9-10):235-40. PubMed ID: 19484206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR-based proton density fat fraction (PDFF) of the vertebral bone marrow differentiates between patients with and without osteoporotic vertebral fractures.
    Gassert FT; Kufner A; Gassert FG; Leonhardt Y; Kronthaler S; Schwaiger BJ; Boehm C; Makowski MR; Kirschke JS; Baum T; Karampinos DC; Gersing AS
    Osteoporos Int; 2022 Feb; 33(2):487-496. PubMed ID: 34537863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D.
    Hara T; Hijikata Y; Matsubara Y; Watanabe N
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013424. PubMed ID: 34231877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative ultrasound and bone mineral density are equally strongly associated with risk factors for osteoporosis.
    Frost ML; Blake GM; Fogelman I
    J Bone Miner Res; 2001 Feb; 16(2):406-16. PubMed ID: 11204441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence of vertebral fractures and health-related quality of life in postmenopausal women.
    Rostom S; Allali F; Bennani L; Abouqal R; Hajjaj-Hassouni N
    Rheumatol Int; 2012 Apr; 32(4):971-80. PubMed ID: 21243498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing quality of life in Moroccan postmenopausal women with osteoporotic vertebral fracture assessed by ECOS 16 questionnaire.
    Abourazzak FE; Allali F; Rostom S; Hmamouchi I; Ichchou L; El Mansouri L; Bennani L; Khazzani H; Abouqal R; Hajjaj-Hassouni N
    Health Qual Life Outcomes; 2009 Mar; 7():23. PubMed ID: 19284667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women.
    Bonadonna S; Mazziotti G; Nuzzo M; Bianchi A; Fusco A; De Marinis L; Giustina A
    J Bone Miner Res; 2005 Oct; 20(10):1837-44. PubMed ID: 16160741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between Osteoporotic Vertebral Compression Fractures and Age, Bone Mineral Density, and European Quality of Life-5 Dimensions in Korean Postmenopausal Women: A Nationwide Cross-sectional Observational Study.
    Cho MJ; Moon SH; Lee JH; Lee JH
    Clin Orthop Surg; 2021 Jun; 13(2):207-215. PubMed ID: 34094011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deterioration of Cortical and Trabecular Microstructure Identifies Women With Osteopenia or Normal Bone Mineral Density at Imminent and Long-Term Risk for Fragility Fracture: A Prospective Study.
    Chapurlat R; Bui M; Sornay-Rendu E; Zebaze R; Delmas PD; Liew D; Lespessailles E; Seeman E
    J Bone Miner Res; 2020 May; 35(5):833-844. PubMed ID: 31821619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Balloon kyphoplasty: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(12):1-45. PubMed ID: 23074451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparisons of TBS and lumbar spine BMD in the associations with vertebral fractures according to the T-scores: A cross-sectional observation.
    Lee JE; Kim KM; Kim LK; Kim KY; Oh TJ; Moon JH; Choi SH; Lim S; Kim SW; Shin CS; Jang HC
    Bone; 2017 Dec; 105():269-275. PubMed ID: 28963079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
    Wells GA; Hsieh SC; Zheng C; Peterson J; Tugwell P; Liu W
    Cochrane Database Syst Rev; 2022 May; 5(5):CD004523. PubMed ID: 35502787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
    Levis S; Theodore G
    J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.